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Although pathogen inactivation by g-radiation is an
attractive approach for whole-organism vaccine
development, radiation doses required to ensure
sterility also destroy immunogenic protein epitopes
needed to mount protective immune responses. We
demonstrate the use of a reconstituted manganous
peptide complex from the radiation-resistant bacte-
rium Deinococcus radiodurans to protect protein
epitopes from radiation-induced damage and un-
couple it from genome damage and organism killing.
The Mn2+ complex preserved antigenic structures in
aqueous preparations of bacteriophage lambda,
Venezuelan equine encephalitis virus, and Staphylo-
coccus aureus during supralethal irradiation (25–40
kGy). An irradiated vaccine elicited both antibody
and Th17 responses, and induced B and T cell-
dependent protection against methicillin-resistant
S. aureus (MRSA) in mice. Structural integrity of
viruses and bacteria are shown to be preserved at
radiation doses far above those which abolish infec-
tivity. This approach could expedite vaccine produc-
tion for emerging and established pathogens for
which no protective vaccines exist.
INTRODUCTION
Ionizing radiation has been reported as a vaccine development
strategy since the early days of vaccinology (Moore and Ker-
sten, 1936). The sterilizing effects of ionizing radiation (X-rays
and g-rays) on targeted organisms are usually ascribed to theCell Hsum of two indiscriminately destructive processes. ‘Direct
action’ refers to the unavoidable damaging effects of energy
deposited by photons, damage which predominates in deeply
frozen (80C) or dry preparations (Ward, 1988; Ito et al.,
1993). In contrast, the overwhelming majority of cellular lesions
in aqueous preparations are caused by the ‘indirect action’ of
reactive oxygen species (ROS) formed from water (Ward,
1988; Ito et al., 1993; Daly, 2009). Nucleic acids, protein and
viability of viruses and bacteria generally display near-exponen-
tial decay during irradiation (Daly et al., 2010; Sullivan et al.,
1971; Krisch et al., 1991; Daly, 2012; Daly et al., 2004; Daly
et al., 2007). For a given target, inactivation by ionizing radiation
in aqueous preparations occurs at doses which are typically
4-5 times lower than when deeply frozen. Frozen or not, the
major drawback of vaccine approaches which apply ionizing
radiation has been the inability to uncouple genome damage
from epitope damage. At doses needed to kill an organism,
oxidative modifications of protein epitopes and consequent
alteration or abolishment of their antibody binding specificity
can render irradiated vaccines nonprotective (Hruskova´,
1969; Reitman et al., 1970; Martin et al., 2010). Typically, as
genome-size decreases, the dose of g-rays needed to sterilize
an organism increases, with viruses presenting the greatest
challenge to preparing irradiated vaccines (Alsharifi and Mu¨ll-
bacher, 2010). In order to preserve the maximum number of
epitopes, radiation exposure is usually limited to the minimum
dose needed to inactivate or attenuate a pathogen. However,
the greater immunogenic potency of vaccines prepared at
lower doses is offset by inherent risks including host cell
reactivation of damaged viral genomes (Eady et al., 1992)
and directed evolution of bacterial radiation resistance (Harris
et al., 2009). Ideally, an irradiated vaccine would be prepared
at doses far greater than those needed to eliminate infectivity
while maintaining epitope integrity needed to mount a protective
immune response.ost & Microbe 12, 117–124, July 19, 2012 ª2012 Elsevier Inc. 117
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Deinococcus Mn-Complex Protects Irradiated VaccineDirect damage by g-rays accumulates at a rate proportional to
dose and does not discriminate between DNA and proteins.
However, it may be possible to selectively protect proteins
from the far more damaging indirect effects of g-rays in aqueous
preparations, while leaving DNA open to ROS attack. This
hypothesis is supported by recent findings for Deinococcus ra-
diodurans, a bacterium which demonstrates extreme resistance
to ionizing radiation (Daly, 2012; Slade and Radman, 2011). The
amount of protein damage caused in D. radiodurans by a given
dose of g-rays is substantially less than in naturally radiosensi-
tive organisms, but the amount of DNA damage is about the
same (Daly, 2009; Daly, 2012; Krisko and Radman, 2010; Krisko
et al., 2012). Protein-free cell extracts of D. radiodurans are
highly enriched in Mn2+ complexes which specifically protect
proteins from ROS damage (Daly et al., 2010). Based on the
composition of D. radiodurans extracts, we reconstituted an
extremely radioprotective complex consisting of Mn2+ and a
decapeptide (DP; H-Asp-Glu-His-Gly-Thr-Ala-Val-Met-Leu-
Lys-OH) in orthophosphate (Pi) buffer (Daly et al., 2010). Mn2+
and orthophosphate form complexes which catalytically remove
superoxide (O2
,-) via a disproportionation mechanism (Barnese
et al., 2008); and amino acids and peptides, which scavenge
hydroxyl radicals (OH,) very efficiently (Daly et al., 2010), form
complexes with Mn2+ which catalytically decompose hydrogen
peroxide (H2O2) (Berlett et al., 1990). When combined in vitro,
the constituents of Mn-DP-Pi (1 mM MnCl2, 3 mM DP, 25 mM
Pi) interacted synergistically in preventing the inactivation of
enzymes during high-dose irradiation (Daly et al., 2010).
In vitro at 50,000 Gy, Mn-DP-Pi preserved 50% activity of the
dodecameric enzyme glutamine synthetase (622 kDa), which
is normally inactivated by 150 Gy; however, Mn-DP-Pi did not
significantly protect DNA from double strand breaks (DSBs),
the most serious form of DNA damage (Daly et al., 2010;
Daly, 2012). The protection of irradiated aqueous proteins by
mixtures of Mn2+, Pi, peptides and other small molecules is
highly dependent on the presence and concentration of Mn2+.
We previously showed that radioprotection was lost when
Mn2+ was substituted with Mg2+, Ca2+, Fe2+, Ni2+, Cu2+or
Zn2+. The highest levels of protection against radiation-induced
ROS were conferred by mixtures of 3 mM DP and 1 mMMn2+ in
25 mM Pi, which represent physiological concentrations in
D. radiodurans (Daly et al., 2010). Evidently, the quaternary
structures of proteins and their functions can be preserved in
aqueous solution by Mn-DP-Pi at doses of ionizing radiation
which destroy similarly treated DNA (Daly et al., 2010). We
now demonstrate that when applied exogenously, Mn-DP-Pi
preserves immunogenic epitopes on intact viruses and bacteria
exposed to doses of g-rays which are far greater than needed to
destroy their genomes.
RESULTS
Uncoupling Genome Damage from Epitope Damage in
Irradiated Viruses
Inactivation of viruses by ionizing radiation proceeds through
damage in nucleic acids, but also by destruction of protein.
Bacteriophage inactivation mediated by protein damage is
caused by loss of adsorption, and by disruption of the phage
head that leads to discharge of DNA into the medium (Watson,118 Cell Host & Microbe 12, 117–124, July 19, 2012 ª2012 Elsevier I1952; Luthjens and Blok, 1969). We tested the ability of Mn-
DP-Pi to protect irradiated bacteriophage l, which infects
Escherichia coli. The phage particle tail recognizes and binds
to its host, causing dsDNA (48.5 kbp) in the head of the phage
to be ejected through the tail into the bacteria, ultimately
causing cell lysis. For a given l phage preparation exposed to
0-40 kGy in the presence or absence of Mn-DP-Pi, we deter-
mined virus inactivation, DNA and protein damage, and immu-
nogenic epitope preservation (Figure 1). In Pi buffer alone, 109 l
phage were sterilized by 5 kGy (Figure 1A). When irradiated in
Mn-DP-Pi, the dose required to sterilize the l phage was
increased 5 times, but DNA was only approximately 2 times
more resistant to DSBs (Figures 1A and 1B). Thus, we attributed
the increase in l phage survival in Mn-DP-Pi mainly to protein
protection. This was confirmed by analysis of phage proteins
(Figure 1C). In l phage exposed to 40 kGy in Pi buffer alone,
there was loss of the two major phage proteins (head,
38 kDa; tail, 32 kDa). In contrast, there was no significant loss
of these proteins in l phage exposed to 40 kGy in Mn-DP-Pi
(Figure 1C). Rabbit antibodies raised against nonirradiated l
phage were used to determine the preservation of epitopes of
l phage irradiated in the absence or presence of Mn-DP-Pi (Fig-
ure 1D, I). Mn-DP-Pi preserved the immunogenicity of head and
tail proteins at 40 kGy. By comparison, antibody binding by l
phage irradiated in Pi buffer alone was diminished at 10 kGy
and abolished at 30 kGy (Figure 1D, I). We then raised anti-
bodies against l phage exposed to 40 kGy in Mn-DP-Pi, an
approach which conceivably could be used to develop inacti-
vated irradiated vaccines for any purified virus. These anti-
bodies bound l phage proteins (Figure 1D, II) similarly to the
antibodies raised against nonirradiated l phage (Figure 1D, I).
Thus, immunogenic epitope destruction was uncoupled from
DNA damage and killing of l phage during irradiation in Mn-
DP-Pi.
As an irradiated viral vaccine ideally would be based on a fully
inactivated virus that displays undamaged surface protein
conformations, we examined the distinctive morphological and
adsorption properties of l phage after exposure to 40 kGy (Fig-
ure S1). Compared to nonirradiated l phage (Figure S1A), l
phage particles irradiated in Pi buffer alone lost their tails by 40
kGy (Figure S1B, I) and the phage heads were rendered vulner-
able to rupture (Figure S1B, II). These structural changes tracked
with dose-dependent increases in tail and head protein damage,
and loss in immunogenicity (Figures 1C and 1D). In contrast,
head and tail morphologies were preserved in l phage particles
exposed to 40 kGy in Mn-DP-Pi (Figure S1B, I and II). Further, l
phage exposed to 40 kGy in Mn-DP-Pi retained their ability to
adsorb to E. coli (Figure S1C, I and II). Thus, for l phage particles
exposed to supralethal doses of g-rays (40 kGy) inMn-DP-Pi, the
structural integrity and binding capacities of the whole viruses
were preserved (Figure S1), and their immunogenic properties
were indistinguishable from nonirradiated l phage (Figure 1D).
As the genomes of l phage (48.5 kb) exposed to 40 kGy in
Mn-DP-Pi were obliterated (Figure 1B), this approach presents
itself as an effective route to preparing highly immunogenic
lethally-irradiated intact viral vaccines.
We then tested the Mn-DP-Pi irradiation approach on
Venezuelan equine encephalitis virus (VEEV), an important
human pathogen which causes encephalitis and for which anc.
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l Figure 1. Uncoupling Genome Damage and
Killing from Epitope Destruction in Viruses
Irradiated in Mn-DP-Pi
(A) Bacteriophage lambda survival. For batches
of 109 phage, complete inactivation (loss of all
pfu) occurred at 5 kGy in Pi buffer, and 25 kGy
in Mn-DP-Pi. 0 on y axis corresponds to 100%
survival.
(B) Bacteriophage l DNA damage assessed
by Southern blotting using a 32P-labeled l DNA
probe.
(C) l protein damage assessed by SDS-poly-
acrylamide gel electrophoresis and visualized by
Coomassie staining. l phage head protein (H) and
tail protein (T).
(D) Protection of antibody binding epitopes of l
phage assessed by western blotting using dupli-
cate gels of the one shown in panel (C). I, Anti-
bodies raised against nonirradiated l phage; II,
Antibodies raised against l phage exposed to
40 kGy in Mn-DP-Pi: Mn, 1 mM MnCl2; DP,
3 mM decapeptide (DP; H-Asp-Glu-His-Gly-
Thr-Ala-Val-Met-Leu-Lys-OH); Pi, 25 mM potas-
sium phosphate buffer (pH 7.4). pfu, plaque
forming units; EC, purified E. coli proteins
(1.25 mg); M, protein size standards. Viability
assays for phage irradiated in Pi or Mn-DP-Pi were
in triplicate, with standard deviations shown. Also
see Figure S1.
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Deinococcus Mn-Complex Protects Irradiated Vaccinelicensed protective killed vaccine does not exist (Paessler and
Weaver, 2009). VEE viruses are a group of serologically related
positive-stranded RNA viruses of the genus Alphavirus in the
family Togaviridae. V3526 is a live attenuated strain derived
from a full-length infectious clone of VEEV, and previous studies
showed loss of antibody binding after inactivation by g-rays
on dry ice, which appeared to limit its efficacy as a vaccine
(Reitman et al., 1970; Martin et al., 2010). We tested the infec-
tivity and antibody binding capacity of aqueous V3526 prepara-
tions irradiated to 0-40 kGy in the presence or absence of
Mn-DP-Pi. At 10 kGy in Pi buffer alone, loss of infectivity of
V3526 (Figure 2A and Table S1) coincided with the initial marked
decay in antibody binding capacity of PE2 (Figure 2B), a surface
glycoprotein of V3526; the reactivity of PE2 in Pi buffer with the
antibody was extinguished by 30 kGy. In stark contrast, PE2 of
V3526 irradiated in Mn-DP-Pi retained its antibody binding
capacity at 40 kGy (Figure 2B), but Mn-DP-Pi did not increase
survival of this ssRNA virus (Figure 2A and Table S1). Single-
strand breaks (SSBs) are lethal in ssRNA genomes but not
in dsDNA genomes (Slade and Radman, 2011). This renders
SSBs in irradiated V3526 the main cause of virus inactivationCell Host & Microbe 12, 117–in Pi buffer and Mn-DP-Pi. However,
in irradiated lambda phage particles,
which contain dsDNA genomes, protein
damage limits survival in Pi buffer at lower
doses but DSBs become the critical inac-
tivating events at higher doses in Mn-DP-
Pi, when lambda proteins are protected
(Figure 1A). Thus, Mn-DP-Pi uncoupled
killing from the destruction of antigenic
epitopes for both V3526 and lambdaphage during gamma-irradiation of aqueous preparations at
doses extending to at least 40 kGy.
Preparing a Mn-DP-Pi-Irradiated Bacterial Vaccine
The functional redundancy and larger number of proteins ex-
pressed by bacteria make them more likely to evade single
subunit vaccines than viruses. Current bacterial vaccines almost
exclusively target organisms that utilize single toxins or capsular
polysaccharides as a dominant virulence strategy (Plotkin and
Plotkin, 2008). Development of vaccines against bacteria that
employ alternative or multiple virulence mechanisms remains
a significant challenge as exemplified by Staphylococcus
aureus. S. aureus is responsible for the majority of skin and
soft tissue infections in humans. Complications arising from
these infections are becoming increasingly problematic with
the widespread emergence of antibiotic-resistant bacterial
strains. Invasivemethicillin-resistant S. aureus (MRSA) infections
result in18,500 deaths annually in the United States, more than
any other single infectious agent and exceeding the number of
deaths associated with HIV/AIDS, viral hepatitis and influenza
combined (Miller and Cho, 2011; Chambers and Deleo, 2009).124, July 19, 2012 ª2012 Elsevier Inc. 119
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Figure 2. Irradiated VEEV (Strain V3526): Virus Infectivity and
Epitope Protection in the Presence or Absence of Mn-DP-Pi
(A) Infectivity following irradiation assessed in vitro by the cytopathic effect
(CPE) assay after 5 successive passages in Vero cells (also see Table S1). Live
cells are stained by crystal violet.
(B) Protection of antibody binding epitopes assessed bywestern blotting using
the monoclonal antibody 13D4-1, which binds the E3 domain of the PE2
glycoprotein of V3526. (+), V3526 irradiated in Mn-DP-Pi. (-), V3526 irradiated
in Pi buffer alone. MC, no virus, medium control. D, dimer of PE2. Other
abbreviations as in Figure 1.
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Deinococcus Mn-Complex Protects Irradiated VaccineThere has been considerable interest in developing a vaccine
against S. aureus, with notable clinical trial failures of vaccines
directed against limited epitopes (Schaffer and Lee, 2009; Ko-
bayashi and DeLeo, 2011; McKenna, 2012).
Multiple bacterial epitopes included in a whole-cell vaccine
would improve the chance of protection against the manifold
virulence strategies of MRSA. We therefore tested if the ability
of Mn-DP-Pi to protect purified enzymes (Daly et al., 2010) and
viral particles (Figures 1 and 2) could be extended to proteins
contained within the relative structural complexity of bacteria.
This possibility was supported by the finding that the native
morphology of E. coli which was lethally-irradiated (25 kGy) in
Mn-DP-Pi was maintained and the cells could adsorb l phage
(Figures S1D and S1E). In contrast, E. coli cells exposed to 25
kGy in Pi buffer alone were extremely damaged (Figure S1F).
As l phage/host binding is mediated by the LamB receptor, an
integral outer membrane protein of E. coli (Gehring et al.,
1987), Mn-DP-Pi was inferred to have protected E. coli surface
proteins from oxidative damage at 25 kGy. We further tested
this approach by preparing an irradiated bacterial vaccine using
MRSA.
We first tested the effect of Mn-DP-Pi on MRSA (strain
USA300) survival. The radiation resistance of MRSA in Mn-DP-
Pi was only slightly increased over irradiation in Pi buffer, with
all viable cells killed by 2 kGy under both conditions (Figure 3A).
To assess if Mn-DP-Pi protected surface antigenic structures,
we coated plates with the Wood 46 strain of S. aureus that had
been irradiated in the absence or presence of Mn-DP-Pi, and
then incubated the coated plates with immune serum from
mice previously infected withMRSA.We usedWood 46 because
it lacks protein A, a virulence factor that binds the Fc portion of
IgG molecules; therefore, any serum antibody bound to Wood
46 should reflect specific binding of staphylococcal epitopes
and not nonspecific binding by protein A that would occur with
MRSA USA300. We found that Wood 46 exposed to 25 kGy in
Mn-DP-Pi (MnDP-Wood 46) showed enhanced anti-MRSA IgG
binding compared to Wood 46 irradiated in Pi buffer, confirming120 Cell Host & Microbe 12, 117–124, July 19, 2012 ª2012 Elsevier Ipreservation of antibody targets (Figure 3B). Irradiated prepara-
tions of MnDP-Wood 46 bound less IgG than nonirradiated
preparations (Figure 3B), supporting that further optimization of
protection against ionizing radiation is possible. Mn-DP-Pi simi-
larly preserved antibody binding by irradiated MRSA USA300
(Figure 3B), although for this strain we cannot rule out that
some of the detected antibody binding may be due to preserved
functionality of protein A.
To test if epitope protection by Mn-DP-Pi translated to
enhanced immune responses in vivo, we immunized mice with
MRSA USA300 that had been exposed to 25 kGy in the absence
(IRS, Irradiated Staphylococcus) or presence (MnDP-IRS) of Mn-
DP-Pi. The preparations were pelleted and washed after irradia-
tion to remove soluble Mn-DP-Pi, and then resuspended in
complete Freund’s adjuvant (CFA). Compared to mice immu-
nized with IRS, mice immunized with MnDP-IRS generated
higher anti-S. aureus serum IgG titers (Figure 3C). The higher
levels of antibody in serum from mice immunized with MnDP-
IRS (Figure 3C) compared to serum from previously infected
mice (Figure 3B) further supported the immunogenicity of
MnDP-IRS. However, serum from IRS- and MnDP-IRS-immu-
nized mice showed equivalent ability to promote opsonophago-
cytosis-mediated killing of MRSA (Figure 3D).
We next used a mouse model of subcutaneous MRSA infec-
tion to evaluate the ability of MnDP-IRS immunization to elicit
protective immunity. In this model, mice infected subcutane-
ously with MRSA USA300 develop abscesses that peak in size
between 3-5 days after infection and then resolve between
days 10-14. Consistent with human disease, a prior infection
does not protect mice from subsequent challenge with the
same organism (Figure S2A). Previously infected mice did not
show evidence of a protective adaptive immune response,
developing only low titer serum antibody (Figure S2B). Moreover,
compared to mice encountering a primary infection, infected
tissue upon a second challenge of previously infected mice did
not show increased induction of interleukin-17 (IL-17), a cytokine
recently identified as contributing to anti-staphyloccal immunity
(Lin et al., 2009; Cho et al., 2010; Narita et al., 2010; Puel et al.,
2011) (Figure S2C). However, mice immunized with MnDP-IRS+
CFA showed decreased abscess formation upon challenge two
weeks after the last immunization (Figure 4A). Compared to mice
immunized with IRS (either in phosphate buffered saline (PBS) or
CFA), mice immunized with MnDP-IRS+CFA had significantly
decreased abscess size (Figure 4B) and skin MRSA bacterial
burden (Figure 4C). MnDP-IRS immunization in PBS without
adjuvant showed a lesser degree of protection (Figures 4B
and 4C). Importantly, Mn-DP-Pi did not confer any antigen-
independent protection when administered without MRSA (Fig-
ure S3A), and immunization with MnDP-IRS was also protective
when used with alum, an adjuvant approved for clinical use (Fig-
ure S3B). To address if the vaccine-induced adaptive immune
response was dependent on B cell antibody production or
effector T cells, we immunized B cell-deficient (mMT) mice, or
depleted CD4 T cells in wild-type mice prior to challenge. B
cell-deficiency did not reduce vaccine protection. CD4 T cell-
depletion diminished protection partially, and loss of both B cells
and CD4 T cells abrogated protection (Figures 4D and 4E). Of
note, B cell deficiency alone, or administration of isotype control
antibody, showed a protective trend that was statisticallync.
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Figure 3. Mn-DP-Pi Protects Staphylo-
coccal Epitopes from Radiation Damage
but Does Not Increase Survival
(A) Viability of Staphylococcus aureus (MRSA
USA300 strain) after exposure to ionizing radiation
in the absence or presence of Mn-DP-Pi.
(B) Binding of anti-MRSA IgG in immune serum
(1:5000 dilution) to protein A-deficient Wood 46
strain of S. aureus or MRSA USA300 that had been
irradiated with 25 kGy in the absence or presence
of Mn-DP-Pi.
(C) Anti-S. aureus IgG titers in serum from mice
immunized in complete Freund’s adjuvant (CFA)
with MRSA USA300 irradiated in the absence (IRS)
or presence (MnDP-IRS) of Mn-DP-Pi.
(D) Recovery of MRSA USA300 after op-
sonophagocytosis-mediated killing by RAW 264.7
macrophages in the presence of titrated serum
pooled from mice immunized as indicated.
Data are representative of 2–3 independent ex-
periments and show mean values from triplicate
samples (panels A and B) or n = 4 mice (panels C
and D). Error bars reflect SEM (standard error of
the mean). Also see Figure S2.
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Deinococcus Mn-Complex Protects Irradiated Vaccinenonsignificant. MnDP-IRS immunization inducedMRSA-specific
IL-17 production from splenic CD4 T cells (Th17 cells) that was
enhanced compared to unimmunized or IRS-immunized mice
(Figure 4F). There was no difference between groups in produc-
tion of MRSA-specific interferon-g, IL-4, IL-5, IL-10, or IL-13
(data not shown). There was a correspondingly greater influx of
Th17 cells into skin abscesses in MnDP-IRS-immunized mice,
and the increased IL-17 response seen in the abscess tissue de-
pended on CD4 T cells (Figures S3C and S3D). Together, these
data suggest that MnDP-IRS immunization elicits antibody- and
Th17 cell-mediated immunity that combine to protect against
staphylococcal skin infection.
DISCUSSION
Recent work suggests that pathogens killed by ionizing radiation
are more immunogenic than those killed by heat or chemicals
(Datta et al., 2006). The use of Mn-DP-Pi during aqueous ionizing
irradiations to further preserve immunogenicity while eliminating
infectivity provides an effective approach for the production of
whole-microbe killed vaccines. As the Mn-DP-Pi complex works
as an extremely efficient ROS scavenger, it would not signifi-
cantly protect epitopes in deeply frozen or dried irradiated prep-
arations (Daly, 2012; Ward, 1988; Ito et al., 1993). Importantly,
Mn-DP-Pi does not rescue organisms from supralethal (>25
kGy) doses of radiation (Figures 1–3). Thus, whole-microbe
vaccines could prospectively be developed against any class
of cultivatable infectious organism, including viruses, bacteria,
fungi, protozoa, and multicellular parasites. Eliminating the
need for identification and production of recombinant protein
targets, and utilizing relatively easy access to irradiation facili-
ties, make this approach rapid, safe, cost-effective, and readily
scalable. With Mn-DP-Pi, we preserved viral epitopes (Figures
1D and 2B) at g-ray doses far above those needed to
ensure sterilization of the aqueous preparations. Similarly, weCell Hpreserved the immunogenicity of MRSA (Figure 3) at g-ray
doses far above those needed to sterilize even the most radia-
tion-resistant bacteria (Daly, 2009; Daly, 2012; Slade and
Radman, 2011). This underscores the advantages of using
Mn-DP-Pi to uncouple epitope destruction from killing, thereby
ensuring the opportunity to generate vaccines which are abso-
lutely noninfective yet highly immunogenic and protective.
The rapidity of vaccine development that could be achieved
by killing of whole isolated pathogens also makes this an attrac-
tive approach against bioterror threats (Hayden, 2011) and
emerging infections caused by poorly characterized new or
rapidly mutating agents, such as pandemic influenza and HIV
(Alsharifi and Mu¨llbacher, 2010).
Our data from the MRSA skin infection model suggests there
are immunological advantages with a whole-cell killed bacterial
vaccine. The ability to induce both antibody- and CD4 T cell-
mediated protective responses is likely enhanced by the presen-
tation of multiple epitopes. Antibody-mediated protection is the
main focus of most current vaccine development, but our data
suggests T cell secretion of IL-17 may play an important role.
Immune responses that protect skin and mucosal barriers have
been particularly difficult to achieve with vaccines. Thus, the
ability to elicit protection against MRSA at the skin holds
particular promise for the ongoing epidemic of cutaneous
MRSA skin infection that affects healthy individuals as well as
individuals with predisposing conditions such as atopic derma-
titis. Natural infection in these individuals does not induce
protective immunity against subsequent infections, so the effi-
cacy of the MnDP-IRS vaccine promises to further elucidate
the requirements for anti-staphylococcal skin immunity. Preven-
tion of hospital-acquired invasive MRSA infections that occur
after iatrogenic breaches of the skin barrier may involve dif-
ferent immune mechanisms that will need to be tested in appro-
priate models. Optimization of strain, culture conditions, growth
stage-dependent epitope presentation, irradiation conditions,ost & Microbe 12, 117–124, July 19, 2012 ª2012 Elsevier Inc. 121
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Figure 4. Immunization with a Mn-DP-Pi-
Based Irradiated MRSA Vaccine Protects
against Staphylococcal Skin Infection
(A) Skin lesions in wild-type (WT) mice. Three
representative mice/group are shown with lesions
demarcated in red. Lesions were photographed
6 days after challenge, which occurred 14 days
after the last immunization.
(B) Daily lesion area in WT mice.
(C) Skin MRSA burden in WTmice. Colony forming
units (CFU) were determined 6 days after chal-
lenge.
(D–F) WT or B cell-deficient (mMT) mice were
immunized and challenged as in panels (A)–(C).
Lesion area (panel D). Skin CFU (panel E).
Supernatant IL-17 from splenic CD4 T cells re-
stimulated with unpulsed or MRSA-pulsed
dendritic cells (DC) (panel F).
In all studies, mice were immunized with IRS or
MnDP-IRS in PBS or CFA on day 0 and day 14. On
day 28,micewere challenged subcutaneouslywith
107 CFU of live MRSA. Control antibody (CTRL Ab)
or depleting antibody against CD4 T cells (aCD4)
was administered to the indicated groups 24 hr
prior to challenge. Data are representative of 2–3
independent experiments. n = 4–10 mice/group.
Error bars reflect SEM. Asterisks indicate p value
compared to unimmunized (panels B and C),
immunized WT (panel D) or indicated (panels E
and F) group (*p < 0.05, **p < 0.01, ***p < 0.001,
ns = nonsignificant). Also see Figure S3.
Cell Host & Microbe
Deinococcus Mn-Complex Protects Irradiated Vaccineand adjuvant may further enhance the immunogenicity and effi-
cacy of a Mn-DP-Pi-irradiated vaccine.
The simplicity and economy of killing a whole organism that
will elicit immunity against multiple epitopes is appealing
compared to the costs and time required to molecularly char-
acterize pathogens and develop recombinant vaccines. Our
studies provide a proof-of-concept that preservation of protein
epitopes by Mn-DP-Pi enhances the immunogenicity of whole
viruses and bacteria killed by supralethal irradiation in aqueous
preparations. The doses of g-rays used here (25-40 kGy) far
exceed the outer limits for survival of the vast majority of
bacteria, viruses, simple eukaryotes and animals (Daly, 2009),
making this inactivation approach applicable to any pathogen.
For radiation-sensitive organisms, including MRSA (Figure 3A),
sterilization doses could be reduced significantly, which would
be expected to further reduce damage to epitopes needed to
develop a protective immune response while still maintaining
an adequate margin of safety to ensure complete inactivation.
Thus, our Mn-DP-Pi irradiated vaccine approach represents
a safe and rapidly adaptable vaccine strategy against any
emerging or existing infectious disease.122 Cell Host & Microbe 12, 117–124, July 19, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
(Also seeSupplemental Experimental Procedures.)
Mn-DP-Pi and Assembly of Viral and
Bacterial Vaccine Preparations prior to
Irradiation
The synthetic decapeptide (DP) H-Asp-Glu-
His-Gly-Thr-Ala-Val-Met-Leu-Lys-OH (Daly et al.,2010) was custom-synthesized by American Peptide Co. Inc., Sunnyvale,
CA. Stock solutions of 30 mM DP (in H2O) were authenticated for sequence
and concentration byHPLC-MS, and stored at80C. Prior to irradiation, puri-
fied bacteriophage lambda particles (1012 plaque forming units (pfu)/ml)
(Supplemental Experimental Procedures) were adjusted to 1 mM MnCl2,
3 mM DP, 25 mM potassium phosphate (Pi) buffer (pH7.4) (Mn-DP-Pi) using
stock solutions: 100 mM MnCl2 (Sigma Chemical Company, St. Louis, MO),
30 mM DP (American Peptide Co. Inc.), and Pi buffer (250 mM) (pH 7.4)
(KH2PO4 and K2HPO4, Sigma) - prepared in H2O from Barnstead Nanopure
ultrapure water purification system, Thermo Scientific, Dubuque, IA. The final
concentration of bacteriophage inMn-DP-Pi was 1.253 1011 pfu/ml. Similarly,
V3526 particles (Supplemental Experimental Procedures) were prepared at
1.12 3 1011 pfu/ml Mn-DP-Pi. MRSA cells (OD600 0.6-0.8) were washed in
25 mM Pi buffer and resuspended at 109 colony forming units (CFU)/ml Mn-
DP-Pi. Mn-DP-Pi suspensions of viruses and bacteria were prepared immedi-
ately prior to irradiation and held on ice prior to and during irradiation.
60Co Irradiations and Survival Curves
All irradiations were performed in air on wet ice with 60Co at 3 kGy/h in a Gam-
macell irradiation unit model 109-68, J. L. Shepherd and Associates, San Fer-
nando, CA. Mn-DP-Pi preparations containing bacteriophage lambda or
V3526 particles were irradiated up to 40 kGy. MRSA cells were irradiated up
to 25 kGy. After each irradiation, 108 MRSA were plated on blood agar plates
after serial dilutions to quantify CFU. No viable MRSA were ever detected at
Cell Host & Microbe
Deinococcus Mn-Complex Protects Irradiated Vaccineirradiation doses greater than 2 kGy. For bacteriophage lambda survival,
6.253 108 particles, irradiated or not, were subjected to tenfold serial dilutions
in TNT broth (10 g/L tryptone, 5g/L NaCl, 1 mg/L thiamine-HCl) (pH 7.3) and
mixed with 100 ml log-phase (OD600 = 0.3) recipient E. coli (C600) culture
(5 3 106 cells). Incubation for adsorption was for 10 min at 37C, followed
by adding 3 ml of molten (46C) TNT 0.5% agar, which were transferred to
TNT 1.5% agar plates. Plaques were counted after overnight incubation at
37C. V3526 survival was determined in liquid suspension by 50% tissue
culture infectivity dose (TCID50), as measured by visible cytopathic effect
(CPE) following five serial passages in Vero cells (Supplemental Experimental
Procedures, and Table S1).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.chom.2012.05.011.
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